173 Epizód

  1. Ep135: John Maraganore on Developing a New Class of Medicines

    Közzétéve: 2023. 05. 08.
  2. Ep134: Emile Nuwaysir on In Vivo Gene Editing Therapies

    Közzétéve: 2023. 04. 24.
  3. Ep133: Catherine Stehman-Breen on Epigenetic Editing Therapies

    Közzétéve: 2023. 04. 12.
  4. Ep132: Eric Dobmeier on Treating Kidney Disease

    Közzétéve: 2023. 03. 28.
  5. Ep131: Ryan Watts on Neuroscience Drug R&D

    Közzétéve: 2023. 03. 14.
  6. Ep130: David Hallal on a Life in Biotech & the Cell Therapy Wave

    Közzétéve: 2023. 02. 28.
  7. Ep129: Joanne Smith-Farrell on Engineered B-Cell Therapies

    Közzétéve: 2023. 02. 14.
  8. Ep128: Rick Berke on Building a Biotech Journalism Outlet to Last

    Közzétéve: 2023. 02. 01.
  9. Ep127: Jeb Keiper on Computational Drug Discovery

    Közzétéve: 2023. 01. 20.
  10. Ep126: DA Wallach on Becoming a Biotech VC

    Közzétéve: 2023. 01. 03.
  11. Ep125: Barry Greene on a New Drug for Depression

    Közzétéve: 2022. 12. 19.
  12. Ep124: Shehnaaz Suliman on Delivery of Genetic Medicines

    Közzétéve: 2022. 11. 08.
  13. Ep123: Tariq Kassum on Single-Cell Analysis for Drug Discovery

    Közzétéve: 2022. 10. 27.
  14. Ep122: Aetna Wun Trombley on Extracellular Protein Degraders

    Közzétéve: 2022. 10. 11.
  15. Ep121: Samantha Truex on Going Upstream Against Severe Asthma

    Közzétéve: 2022. 09. 26.
  16. Ep120: Tim Lu on Gene Circuits for Cell Therapy

    Közzétéve: 2022. 09. 07.
  17. Ep119: Jo Viney on Discovering Treatments for Autoimmune Disease

    Közzétéve: 2022. 08. 22.
  18. Ep118: Ivan Liachko on Assembling Accurate Genomes and Interactomes

    Közzétéve: 2022. 08. 08.
  19. Ep117: Dr. Sanduk Ruit on Restoring Eyesight in the Developing World

    Közzétéve: 2022. 07. 11.
  20. Ep116: Ivana Magovcevic-Liebisch on Precision Neuroscience

    Közzétéve: 2022. 06. 22.

3 / 9

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

Visit the podcast's native language site